Compare QTRX & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | AGL |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Managed Health Care |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.7M | 276.6M |
| IPO Year | 2017 | 2021 |
| Metric | QTRX | AGL |
|---|---|---|
| Price | $7.63 | $0.66 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 17 |
| Target Price | ★ $10.33 | $2.79 |
| AVG Volume (30 Days) | 875.4K | ★ 12.5M |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $130,203,000.00 | ★ $5,885,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.28 | $3.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $4.05 | $0.51 |
| 52 Week High | $12.94 | $6.08 |
| Indicator | QTRX | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 71.38 | 44.80 |
| Support Level | $6.70 | $0.62 |
| Resistance Level | $7.89 | $0.73 |
| Average True Range (ATR) | 0.46 | 0.06 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 89.45 | 64.41 |
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.